Highlight Your Ophthalmology Expertise & Services to Drug Developers with Expanding Retinal Vascular Pipelines

Retinal Vascular Experts Required Your Help With:

In Vitro & In Vivo Models for Retinal Vascular Diseases

Preclinical CROs for Safety & Efficacy

Clinical CROs with Proficiency in Ophthalmology

Optical Biomarkers & Diagnostics

Artificial Intelligence & Retinal Imaging Devices

Why Partner?

Benefit from Market Intelligence in Retinal Vascular Disease Drug Development

Discover new companies within the retinal vascular disease drug development space, such as Annexin Pharmaceuticals, Nanoscope Therapeutics and AMD Therapeutics, to generate new business opportunities and refresh your target client list

Meet & Network with Industry Pioneers from the likes of Bayer, Novartis & Genentech

Generate new business leads by securing invaluable facetime with key decision makers wanting to progress their extended release retinal drugs from preclinical to clinical stages, through structured networking and pre-organized 1-2-1 meetings

Raise Brand Awareness within the Retinal Vascular Community

Benefit from pre- and post-conference in-person exposure to our drug discovery KOLs and increase market share through unique branding formats such as exhibition booths, lead partnership options or even a dedicated presentation to show how your CRO services can help progress their drug discovery and development

Generate Commercial Collaborations with Senior Decision Makers

Make sure your hottest prospects are in the room and part of the discussion by having a wish list of your choice contacted in advance of the event and ensure that you are set up for success in securing significant contacts for desired commercial gain  

Who Can You Meet?

Attendee Breakdown